Bristol Myers Squibb to Participate in Citi’s 2025 Global Healthcare Conference Nov 26, 2025 06:59AM
Bristol Myers Squibb accepts $7.5 billion in debt tender offers Nov 18, 2025 02:26PM
Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers Nov 18, 2025 02:25PM
Bristol Myers Squibb Announces Early Participation Results, Amendment and Early Settlement of Tender Offers Nov 17, 2025 10:33PM
Bristol Myers Squibb prices €5 billion senior unsecured notes offering Nov 5, 2025 02:47PM
View Older Stories

Nov 5, 2025 02:47PM Bristol Myers Squibb Prices €5 Billion of Senior Unsecured Notes
Nov 3, 2025 04:55AM Bristol Myers Squibb Announces Cash Tender Offers to Purchase Certain Notes
Jun 2, 2025 09:10AM Citi on Bristol-Myers Squibb Co. (BMY): 'ASCO 2025: Early stage ADCs support breadth of oncology portfolio'
Nov 26, 2024 06:59AM Bristol Myers Squibb to Participate in Citi’s 2024 Global Healthcare Conference
Aug 22, 2024 03:25PM Bristol-Myers Squibb-backed Zenas BioPharma files for US IPO
May 21, 2024 06:22AM Citi Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)
Mar 18, 2024 09:52AM Bristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 Billion
Mar 18, 2024 08:45AM Bristol-Myers Squibb (BMY) Completes Acquisition of Karuna Therapeutics (KRTX)
Mar 18, 2024 08:44AM Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics, Strengthening Neuroscience Portfolio
Feb 15, 2024 03:53AM Bristol-Myers Squibb (BMY) Issues $13B of Notes to Fund Acquisitions
Feb 14, 2024 07:57PM Bristol Myers Squibb Prices $13 Billion of Senior Unsecured Notes
Dec 22, 2023 09:13AM PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion
Dec 22, 2023 06:59AM Bristol-Myers Squibb (BMY) to Acquire Karuna Therapeutics (KRTX) for $330/sh or $14B
Dec 22, 2023 06:59AM Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
Nov 20, 2023 12:29PM Midday movers: Microsoft, Boeing, Bristol-Myers Squibb, and more
Nov 20, 2023 08:14AM Citi on Bristol-Myers Squibb Co. (BMY): 'Major Opportunity in AF Remains but BMY Likely Needs to Pivot'
Oct 31, 2023 05:08AM Bristol-Myers Squibb (BMY) Prices $4.5B Senior Unsecured Notes Offering
Oct 30, 2023 08:19PM Bristol Myers Squibb Prices $4.5 Billion of Senior Unsecured Notes
Sep 12, 2022 08:44AM Pre-Open Stock Movers: Bristol-Myers Jumps on FDA Approval, Carvana Gains on Upgrade
Aug 31, 2022 06:59AM Bristol Myers Squibb to Participate in Citi’s 17th Annual BioPharma Conference
Jun 3, 2022 11:39AM Citi Reiterates $90 PT on Bristol-Myers Squibb Co. (BMY), 'We expect some FTC scrutiny...but given the Pfizer/ Arena outcome, we remain hopeful'
May 17, 2022 06:29AM Buffett's Berkshire Hathaway Enters 8 New Stocks, Including Citi and Paramount Global; Adds to Apple and Chevron
Nov 29, 2021 06:45AM 2 Reasons Why Citi Downgraded Merck (MRK) to Neutral Today, Opened a Negative Catalyst Watch
Nov 9, 2020 07:27PM Bristol Myers Squibb Prices $7 Billion of Senior Unsecured Notes
Oct 5, 2020 09:30AM Pre-Open Stock Movers 10/05: (MYOK) (KOS) (EIDX) Higher; (BBIO) (AMC) (DKNG) Lower (more...)
Sep 2, 2020 06:59AM Bristol Myers Squibb to Participate in Citi’s 15th Annual BioPharma Virtual Conference
Mar 24, 2020 08:30AM S&P 500 Buybacks Up 3.2% in Q4, Grim Outlook for 2020
Mar 24, 2020 08:15AM S&P 500 buybacks up 3.2% in Q4 2019; Full Year 2019 down 9.6% from record 2018, as companies brace for a more volatile 2020
Jan 6, 2020 08:50AM Citi Resumes Bristol-Myers Squibb Co. (BMY) at Buy
Dec 31, 2019 09:11AM Dealmakers eye cross-border M&A recovery as mega mergers roll on
Dec 10, 2019 12:05AM Choppy markets leave U.S. bank bonus decisions in limbo
Nov 20, 2019 04:16PM Bristol-Myers Squibb (BMY) Completes Acquisition of Celgene (CELG)
Nov 20, 2019 04:16PM Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a Leading Biopharma Company
Jan 3, 2019 07:06AM Bristol-Myers to buy Celgene for $74 billion in largest biopharma deal
Jan 3, 2019 06:59AM Bristol-Myers Squibb (BMY) to Acquire Celgene Corp. (CELG) for Approx. $74B
Jan 3, 2019 06:58AM Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company
Nov 29, 2018 06:59AM Bristol-Myers Squibb to Take Part in Citi 2018 Global Healthcare Conference
Oct 22, 2018 04:06PM Merck (MRK) Added to Citi Recommended List, Bristol-Myers Squibb (BMY) Removed
Oct 22, 2018 09:32AM Pre-Open Movers 10/22: (ARII) (DVAX) (PETS) Higher; (MRTX) (HAS) (BMY) Lower (more...)
Oct 22, 2018 05:20AM Citi Downgrades Bristol-Myers Squibb Co. (BMY) to Neutral
May 15, 2018 10:14AM Omega's 13F Shows Increase in Ocwen (OCN), Synchrony (SYF), United (UAL), Exits Zynga (ZNGA) (More...)
Apr 25, 2018 06:45AM Bristol-Myers Squibb Co. (BMY) PT Lowered to $62 at Citi
Apr 12, 2018 07:24AM Pfizer (PFE) Made It Clear It Has No Interest in Bristol-Myers Squibb (BMY) - Citi
Apr 12, 2018 06:49AM Bristol-Myers Squibb (BMY): Cutting PT As PFE Backs Away - Citi
Nov 30, 2017 04:59PM Bristol-Myers Squibb to Take Part at the Citi 2017 Global Healthcare Conference
Oct 30, 2017 09:16AM Pre-Open Movers 10/30: (CAA) (ADMS) (DYN) Higher; (PSTI) (CTB) (CENX) Lower (more...)
Oct 18, 2017 06:59AM Bristol-Myers Squibb (BMY): Raising PT To $72 - Citi
Aug 16, 2017 08:36AM Pre-Open Movers 08/16: (URBN) (TGT) (A) (PSTI) (MYL (BMY)
Jun 21, 2017 10:00AM S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017
May 16, 2017 06:57AM Citi Downgrades Pfizer (PFE) to Sell; Risk to EPS Consensus, Needs Major Deal to Hit Numbers
View Older Stories